InVivoMAb anti-mouse IL-2

Villegas-Mendez A, Shaw TN, Inkson CA, et al. Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection. Infect Immun. 2016,84(1):34-46. doi: 10.1128/IAI.01100-15

Srivastava S, Koch MA, Pepper M, et al. Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J Exp Med. 2014,211(5):961-74. doi: 10.1084/jem.20131556

Gasteiger G, Hemmers S, Bos PD, et al. IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med. 2013,210(6):1179-87. doi: 10.1084/jem.20122571

Villegas-Mendez A, de Souza JB, Lavelle SW, et al. IL-27 receptor signalling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signals. PLoS Pathog. 2013,9(4):e1003293. doi: 10.1371/journal.ppat.1003293

Gwyer Findlay E, Villegas-Mendez A, de Souza JB, et al. IL-27 receptor signaling regulates CD4+ T cell chemotactic responses during infection. J Immunol. 2013,190(9):4553-61. doi: 10.4049/jimmunol.1202916

Cho HI, Reyes-Vargas E, Delgado JC, et al. A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy. Cancer Res. 2012,72(8):1986-95. doi: 10.1158/0008-5472.CAN-11-3246

Weber KS, Hildner K, Murphy KM, et al. Trpm4 differentially regulates Th1 and Th2 function by altering calcium signaling and NFAT localization. J Immunol. 2010,185(5):2836-46. doi: 10.4049/jimmunol.1000880

Carlson MJ, West ML, Coghill JM, et al. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood. 2009,113(6):1365-74. doi: 10.1182/blood-2008-06-162420